JV-Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
JV-Med
Largest movements
- Cash +€48,041
up €48,041 (+69.1%), from €69,547 to €117,588
mainly Net result for the year (+€54,805) and Receivables within one year (+€5,034)
- Receivables within one year -€5,034
down €5,034 (-64.7%), from €7,779 to €2,745
- Deferred charges and accrued income +€4,254
up €4,254 (+20.1%), from €21,125 to €25,378
- Reserves +€50,000
new in 2025: €50,000
- Tax, wage and social debts -€7,944
down €7,944 (-67.7%), from €11,729 to €3,786
- Profit (loss) carried forward +€4,805
up €4,805 (+5.5%), from €87,507 to €92,312
- Gross operating margin -€34,270
down €34,270 (-29.9%), from €114,478 to €80,209
- Turnover -€27,154
down €27,154 (-13.6%), from €198,995 to €171,841
- Purchases and services +€7,115
up €7,115 (+8.4%), from €84,517 to €91,632
- Taxes -€2,423
down €2,423 (-10.6%), from €22,847 to €20,423
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €102,753 | €149,768 | +€47,015 | +45.8% |
| Formation expenses | 20 | €1,825 | €1,363 | -€462 | -25.3% |
| Fixed assets | 21/28 | €2,478 | €2,693 | +€216 | +8.7% |
| Tangible fixed assets | 22/27 | €2,478 | €2,693 | +€216 | +8.7% |
| Furniture and vehicles | 24 | €997 | €1,566 | +€569 | +57.1% |
| Other tangible fixed assets | 26 | €1,481 | €1,128 | -€354 | -23.9% |
| Current assets | 29/58 | €98,451 | €145,711 | +€47,261 | +48.0% |
| Amounts receivable within one year | 40/41 | €7,779 | €2,745 | -€5,034 | -64.7% |
| Other amounts receivable | 41 | €7,779 | €2,745 | -€5,034 | -64.7% |
| Cash at bank and in hand | 54/58 | €69,547 | €117,588 | +€48,041 | +69.1% |
| Deferred charges and accrued income | 490/1 | €21,125 | €25,378 | +€4,254 | +20.1% |
| Total equity and liabilities | 10/49 | €102,753 | €149,768 | +€47,015 | +45.8% |
| Equity | 10/15 | €90,507 | €145,312 | +€54,805 | +60.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | - | €50,000 | +€50,000 | |
| Distributable reserves | 133 | - | €50,000 | +€50,000 | |
| Profit (loss) carried forward | 14 | €87,507 | €92,312 | +€4,805 | +5.5% |
| Amounts payable | 17/49 | €12,247 | €4,456 | -€7,790 | -63.6% |
| Amounts payable within one year | 42/48 | €12,151 | €4,264 | -€7,887 | -64.9% |
| Trade debts | 44 | €422 | €478 | +€56 | +13.3% |
| Suppliers | 440/4 | €422 | €478 | +€56 | +13.3% |
| Taxes, remuneration and social security | 45 | €11,729 | €3,786 | -€7,944 | -67.7% |
| Taxes | 450/3 | €11,729 | €3,786 | -€7,944 | -67.7% |
| Accrued charges and deferred income | 492/3 | €96 | €193 | +€97 | +101% |
| Turnover | 70 | €198,995 | €171,841 | -€27,154 | -13.6% |
| Goods, raw materials, services and sundry goods | 60/61 | €84,517 | €91,632 | +€7,115 | +8.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,109 | €1,705 | +€596 | +53.7% |
| Other operating charges | 640/8 | €896 | €736 | -€160 | -17.9% |
| Gross operating margin | 9900 | €114,478 | €80,209 | -€34,270 | -29.9% |
| Operating profit (loss) | 9901 | €112,473 | €77,768 | -€34,705 | -30.9% |
| Financial income | 75/76B | €236 | €270 | +€34 | +14.3% |
| Recurring financial income | 75 | €236 | €270 | +€34 | +14.3% |
| Financial charges | 65/66B | €2,356 | €2,809 | +€453 | +19.2% |
| Recurring financial charges | 65 | €2,356 | €2,809 | +€453 | +19.2% |
| Profit (loss) for the period before taxes | 9903 | €110,353 | €75,229 | -€35,125 | -31.8% |
| Income taxes | 67/77 | €22,847 | €20,423 | -€2,423 | -10.6% |
| Profit (loss) for the period | 9904 | €87,507 | €54,805 | -€32,701 | -37.4% |
| Profit (loss) for the period to be appropriated | 9905 | €87,507 | €54,805 | -€32,701 | -37.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.